Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X‐deficient woman
Pregnancy in women with congenital coagulation factor deficiencies has been associated with adverse fetal outcomes. Recurrent spontaneous abortions, placental abruptions, and premature births are reported, the exact reasons for which are not clear, and management of such patients continues to be a c...
Gespeichert in:
Veröffentlicht in: | American journal of hematology 1994-07, Vol.46 (3), p.241-244 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 244 |
---|---|
container_issue | 3 |
container_start_page | 241 |
container_title | American journal of hematology |
container_volume | 46 |
creator | Kumar, Manjusha Mehta, Paulette |
description | Pregnancy in women with congenital coagulation factor deficiencies has been associated with adverse fetal outcomes. Recurrent spontaneous abortions, placental abruptions, and premature births are reported, the exact reasons for which are not clear, and management of such patients continues to be a challenge. We reviewed the outcome of four pregnancies in a patient with factor X deficiency, and looked at the effect of factor replacement therapy on pregnancy. Her first two pregnancies resulted in the birth of extremely premature babies at 21 and 25 weeks of gestation, both of which died in the neonatal period. The patient was treated with fresh frozen plasma for acute bleeding episodes during these pregnancies. In addition during her second conception she was given factor IX complex [Konyne] prophylactically, but only in the latter half of her pregnancy. During her next two pregnancies she was treated early on during pregnancy, with prophylactic replacement of factor X. She delivered healthy babies at 34 and 32 weeks of gestation, and they are both doing well. We therefore suggest possible mechanisms by which aggressive prophylactic factor support in a female with severe congenital coagulopathy, may improve on fetal outcome. © 1994 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ajh.2830460315 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76505590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76505590</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2845-c39a88fef14fb7bd694cc3fe96b4bbc07ec40d229d06a5d26d503023eee25c013</originalsourceid><addsrcrecordid>eNqFkM9qGzEQh0VpSFyn194KOpTc1hlpJXmVmzFJ0xIIhARyW7TakbNhLW2kXYJvfYQ-Y56ka2yc3nKagd83f_gI-cZgxgD4uXl-mvEiB6EgZ_ITmTDQKiuU5J_JBHLFxh70CfmS0jMAY6KAY3JcMM2ZlBNil8Gv0De9aakNZjW0oTP9U4OJGl_TLuLKG283F_QOuxB7Ghx1YYiHZEs2nhrqjO1DpI9vf_7W6Jox8D19DWvjT8mRM23Cr_s6JQ9Xl_fL6-zm9uev5eIms7wQMrO5NkXh0DHhqnlVKy2szR1qVYmqsjBHK6DmXNegjKy5qiXkwHNE5NICy6fkbLe3i-FlwNSX6yZZbFvjMQypnCsJUmoYwdkOtDGkFNGVXWzWJm5KBuXWajlaLd-tjgPf95uHao31Ad9rHPMf-9wka1oXt2LSARNMjH_yEdM77LVpcfPB0XLx-_q_F_4BczuSJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76505590</pqid></control><display><type>article</type><title>Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X‐deficient woman</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Kumar, Manjusha ; Mehta, Paulette</creator><creatorcontrib>Kumar, Manjusha ; Mehta, Paulette</creatorcontrib><description>Pregnancy in women with congenital coagulation factor deficiencies has been associated with adverse fetal outcomes. Recurrent spontaneous abortions, placental abruptions, and premature births are reported, the exact reasons for which are not clear, and management of such patients continues to be a challenge. We reviewed the outcome of four pregnancies in a patient with factor X deficiency, and looked at the effect of factor replacement therapy on pregnancy. Her first two pregnancies resulted in the birth of extremely premature babies at 21 and 25 weeks of gestation, both of which died in the neonatal period. The patient was treated with fresh frozen plasma for acute bleeding episodes during these pregnancies. In addition during her second conception she was given factor IX complex [Konyne] prophylactically, but only in the latter half of her pregnancy. During her next two pregnancies she was treated early on during pregnancy, with prophylactic replacement of factor X. She delivered healthy babies at 34 and 32 weeks of gestation, and they are both doing well. We therefore suggest possible mechanisms by which aggressive prophylactic factor support in a female with severe congenital coagulopathy, may improve on fetal outcome. © 1994 Wiley‐Liss, Inc.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.2830460315</identifier><identifier>PMID: 8192155</identifier><identifier>CODEN: AJHEDD</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Biological and medical sciences ; congenital coagulopathy ; factor X ; Factor X - therapeutic use ; Factor X Deficiency - congenital ; Factor X Deficiency - drug therapy ; Female ; Fetal Death ; Hematologic and hematopoietic diseases ; Hemorrhage - prevention & control ; Humans ; Infant, Newborn ; Infant, Newborn, Diseases - prevention & control ; Medical sciences ; Obstetric Labor, Premature ; Platelet diseases and coagulopathies ; Pregnancy ; Pregnancy Complications, Cardiovascular - prevention & control</subject><ispartof>American journal of hematology, 1994-07, Vol.46 (3), p.241-244</ispartof><rights>Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2845-c39a88fef14fb7bd694cc3fe96b4bbc07ec40d229d06a5d26d503023eee25c013</citedby><cites>FETCH-LOGICAL-c2845-c39a88fef14fb7bd694cc3fe96b4bbc07ec40d229d06a5d26d503023eee25c013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.2830460315$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.2830460315$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4140232$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8192155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, Manjusha</creatorcontrib><creatorcontrib>Mehta, Paulette</creatorcontrib><title>Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X‐deficient woman</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>Pregnancy in women with congenital coagulation factor deficiencies has been associated with adverse fetal outcomes. Recurrent spontaneous abortions, placental abruptions, and premature births are reported, the exact reasons for which are not clear, and management of such patients continues to be a challenge. We reviewed the outcome of four pregnancies in a patient with factor X deficiency, and looked at the effect of factor replacement therapy on pregnancy. Her first two pregnancies resulted in the birth of extremely premature babies at 21 and 25 weeks of gestation, both of which died in the neonatal period. The patient was treated with fresh frozen plasma for acute bleeding episodes during these pregnancies. In addition during her second conception she was given factor IX complex [Konyne] prophylactically, but only in the latter half of her pregnancy. During her next two pregnancies she was treated early on during pregnancy, with prophylactic replacement of factor X. She delivered healthy babies at 34 and 32 weeks of gestation, and they are both doing well. We therefore suggest possible mechanisms by which aggressive prophylactic factor support in a female with severe congenital coagulopathy, may improve on fetal outcome. © 1994 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>congenital coagulopathy</subject><subject>factor X</subject><subject>Factor X - therapeutic use</subject><subject>Factor X Deficiency - congenital</subject><subject>Factor X Deficiency - drug therapy</subject><subject>Female</subject><subject>Fetal Death</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemorrhage - prevention & control</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infant, Newborn, Diseases - prevention & control</subject><subject>Medical sciences</subject><subject>Obstetric Labor, Premature</subject><subject>Platelet diseases and coagulopathies</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Cardiovascular - prevention & control</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM9qGzEQh0VpSFyn194KOpTc1hlpJXmVmzFJ0xIIhARyW7TakbNhLW2kXYJvfYQ-Y56ka2yc3nKagd83f_gI-cZgxgD4uXl-mvEiB6EgZ_ITmTDQKiuU5J_JBHLFxh70CfmS0jMAY6KAY3JcMM2ZlBNil8Gv0De9aakNZjW0oTP9U4OJGl_TLuLKG283F_QOuxB7Ghx1YYiHZEs2nhrqjO1DpI9vf_7W6Jox8D19DWvjT8mRM23Cr_s6JQ9Xl_fL6-zm9uev5eIms7wQMrO5NkXh0DHhqnlVKy2szR1qVYmqsjBHK6DmXNegjKy5qiXkwHNE5NICy6fkbLe3i-FlwNSX6yZZbFvjMQypnCsJUmoYwdkOtDGkFNGVXWzWJm5KBuXWajlaLd-tjgPf95uHao31Ad9rHPMf-9wka1oXt2LSARNMjH_yEdM77LVpcfPB0XLx-_q_F_4BczuSJQ</recordid><startdate>199407</startdate><enddate>199407</enddate><creator>Kumar, Manjusha</creator><creator>Mehta, Paulette</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199407</creationdate><title>Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X‐deficient woman</title><author>Kumar, Manjusha ; Mehta, Paulette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2845-c39a88fef14fb7bd694cc3fe96b4bbc07ec40d229d06a5d26d503023eee25c013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>congenital coagulopathy</topic><topic>factor X</topic><topic>Factor X - therapeutic use</topic><topic>Factor X Deficiency - congenital</topic><topic>Factor X Deficiency - drug therapy</topic><topic>Female</topic><topic>Fetal Death</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemorrhage - prevention & control</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infant, Newborn, Diseases - prevention & control</topic><topic>Medical sciences</topic><topic>Obstetric Labor, Premature</topic><topic>Platelet diseases and coagulopathies</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Cardiovascular - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Manjusha</creatorcontrib><creatorcontrib>Mehta, Paulette</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Manjusha</au><au>Mehta, Paulette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X‐deficient woman</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>1994-07</date><risdate>1994</risdate><volume>46</volume><issue>3</issue><spage>241</spage><epage>244</epage><pages>241-244</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><coden>AJHEDD</coden><abstract>Pregnancy in women with congenital coagulation factor deficiencies has been associated with adverse fetal outcomes. Recurrent spontaneous abortions, placental abruptions, and premature births are reported, the exact reasons for which are not clear, and management of such patients continues to be a challenge. We reviewed the outcome of four pregnancies in a patient with factor X deficiency, and looked at the effect of factor replacement therapy on pregnancy. Her first two pregnancies resulted in the birth of extremely premature babies at 21 and 25 weeks of gestation, both of which died in the neonatal period. The patient was treated with fresh frozen plasma for acute bleeding episodes during these pregnancies. In addition during her second conception she was given factor IX complex [Konyne] prophylactically, but only in the latter half of her pregnancy. During her next two pregnancies she was treated early on during pregnancy, with prophylactic replacement of factor X. She delivered healthy babies at 34 and 32 weeks of gestation, and they are both doing well. We therefore suggest possible mechanisms by which aggressive prophylactic factor support in a female with severe congenital coagulopathy, may improve on fetal outcome. © 1994 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8192155</pmid><doi>10.1002/ajh.2830460315</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0361-8609 |
ispartof | American journal of hematology, 1994-07, Vol.46 (3), p.241-244 |
issn | 0361-8609 1096-8652 |
language | eng |
recordid | cdi_proquest_miscellaneous_76505590 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adult Biological and medical sciences congenital coagulopathy factor X Factor X - therapeutic use Factor X Deficiency - congenital Factor X Deficiency - drug therapy Female Fetal Death Hematologic and hematopoietic diseases Hemorrhage - prevention & control Humans Infant, Newborn Infant, Newborn, Diseases - prevention & control Medical sciences Obstetric Labor, Premature Platelet diseases and coagulopathies Pregnancy Pregnancy Complications, Cardiovascular - prevention & control |
title | Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X‐deficient woman |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20coagulopathies%20and%20pregnancy:%20Report%20of%20four%20pregnancies%20in%20a%20factor%20X%E2%80%90deficient%20woman&rft.jtitle=American%20journal%20of%20hematology&rft.au=Kumar,%20Manjusha&rft.date=1994-07&rft.volume=46&rft.issue=3&rft.spage=241&rft.epage=244&rft.pages=241-244&rft.issn=0361-8609&rft.eissn=1096-8652&rft.coden=AJHEDD&rft_id=info:doi/10.1002/ajh.2830460315&rft_dat=%3Cproquest_cross%3E76505590%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76505590&rft_id=info:pmid/8192155&rfr_iscdi=true |